Although we did not find an effect of maternal obesity on liver weight, more research is required to answer the question of whether the inhibitory effect of maternal obesity on hepatic Ppara expression contributes to the development of NAFLD in mice. Here, PPARA is linked to metabolic dysfunction-associated steatotic liver disease.